Showing results (31-40 of 117) with videos related to
Sort By:
Pageof 12
Arteriosclerosis, Thrombosis, and Vascular Biology|March 1, 1995
Apolipoprotein A-II production rate is a major factor regulating the distribution of apolipoprotein A-I among HDL subclasses LpA-I and LpA-I:A-II in normolipidemic humansK Ikewaki, L A Zech, M Kindt, et al.Der Anaesthesist|December 13, 2016
[Full-scale simulation in German medical schools and anesthesia residency programs : Status quo]H Baschnegger, O Meyer, A Zech, et al.Journal of Lipid Research|November 11, 1991
In vivo metabolism of apolipoprotein A-I on high density lipoprotein particles LpA-I and LpA-I,A-IID J Rader, G Castro, L A Zech, et al.Annals of Internal Medicine|May 1, 1983
NIH conference. Type III hyperlipoproteinemia: diagnosis, molecular defects, pathology, and treatmentH B Brewer, L A Zech, R E Gregg, et al.The Journal of Clinical Investigation|August 1, 1982
Increased prevalence of apolipoprotein E4 in type V hyperlipoproteinemiaG Ghiselli, E J Schaefer, L A Zech, et al.Lancet (London, England)|August 21, 1982
Phenotype study of apolipoprotein E isoforms in hyperlipoproteinaemic patientsG Ghiselli, R E Gregg, L A Zech, et al.Metabolism: Clinical and Experimental|October 10, 1997
Erdheim-Chester disease: low low-density lipoprotein levels due to rapid catabolismH H Schmidt, R E Gregg, R Shamburek, et al.Archives of Dermatology|February 1, 1989
Etretinate. Persistent serum levels after long-term therapyJ J DiGiovanna, L A Zech, M E Ruddel, et al.Metabolism: Clinical and Experimental|March 1, 1997
The 3H-leucine tracer: its use in kinetic studies of plasma lipoproteinsW R Fisher, V Venkatakrishnan, E S Fisher, et al.The Journal of Clinical Investigation|June 1, 1987
Metabolism of immunoglobulin E in patients with markedly elevated serum immunoglobulin E levelsS C Dreskin, P K Goldsmith, W Strober, et al.Pageof 12